FDA Approves New Pancreatic Treatment Found To Double Time Patients Live Without Disease Progression

FDA Approves New Pancreatic Treatment Found To Double Time Patients Live Without Disease Progression

Source: 
Forbes
snippet: 

Pancreatic cancer is notoriously aggressive and difficult to treat but a recent FDA ruling may help put odds more in patients’ favor. Last week the FDA approved Lynparza for use as a maintenance treatment for certain pancreatic cancer patients. The drug was found to significantly expand the amount of time patients lived without disease progression.